Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vivos Therapeutics

3.87
+0.03500.91%
Post-market: 3.83-0.0359-0.93%18:08 EDT
Volume:61.30K
Turnover:237.52K
Market Cap:29.01M
PE:-2.17
High:4.02
Open:3.83
Low:3.81
Close:3.83
52wk High:7.95
52wk Low:1.98
Shares:7.50M
Float Shares:5.43M
Volume Ratio:0.58
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7775
EPS(LYR):-2.2184
ROE:-262.05%
ROA:-42.48%
PB:6.33
PE(LYR):-1.74

Loading ...

Vivos Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Yesterday

Vivos Therapeutics Q2 EPS $(0.55) Misses $(0.35) Estimate, Sales $3.820M Beat $3.783M Estimate

Benzinga
·
Aug 20

BRIEF-Vivos Therapeutics Q2 Net Income USD -5.013 Million

Reuters
·
Aug 20

Vivos Therapeutics Inc - Q2 REV $3.8 Mln

THOMSON REUTERS
·
Aug 20

Vivos Therapeutics Q2 Basic EPS USD -0.55

THOMSON REUTERS
·
Aug 20

Vivos Therapeutics Q2 Gross Profit USD 2.11 Million

THOMSON REUTERS
·
Aug 20

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

THOMSON REUTERS
·
Aug 20

Press Release: Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

Dow Jones
·
Aug 19

Vivos Therapeutics : Anticipates Material Increase in Net Loss for Three Months Ended June 30, 2025 as Compared to Three Months Ended June 30, 2024

THOMSON REUTERS
·
Aug 15

Vivos Therapeutics Inc. Delays Q2 2025 Financial Report Due to Recent Acquisition

Reuters
·
Aug 15

Vivos Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
Aug 08

Vivos Therapeutics Adds to Management Team to Support Expansion and Growth

GlobeNewswire
·
Jul 30

Vivos Therapeutics Shares Rise After Medicare Approval for VidaSleep

Dow Jones
·
Jul 02

BRIEF-Vivos Therapeutics Inc - Vidasleep Oral Appliance Approved By CMS Pdac

Reuters
·
Jul 01

Vivos Therapeutics Inc. Files Initial Beneficial Ownership Statement for Michael C. Skaff

Reuters
·
Jun 21

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada, Secures Over $11 Million in New Financing

Reuters
·
Jun 14

Vivos Therapeutics Inc. Appoints Baker Tilly as New Auditor Following Merger with Moss Adams

Reuters
·
Jun 07

Equity Markets Close Lower as Trump Proposes New Tariffs on EU, Apple

MT Newswires Live
·
May 24

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires Live
·
May 24

Vivos Issues $1.1 Million Convertible Promissory Note

MT Newswires Live
·
May 24